Demyelination News and Research

RSS
A demyelinating disease is any disease of the nervous system in which the myelin sheath of neurons is damaged. This impairs the conduction of signals in the affected nerves, causing impairment in sensation, movement, cognition, or other functions depending on which nerves are involved.
New brain map reveals insights into multiple sclerosis development

New brain map reveals insights into multiple sclerosis development

Discovery of gene silencer offers hope for autosomal dominant leukodystrophy

Discovery of gene silencer offers hope for autosomal dominant leukodystrophy

Pheno Therapeutics receives clinical trial authorization for novel multiple sclerosis therapeutic

Pheno Therapeutics receives clinical trial authorization for novel multiple sclerosis therapeutic

Pheno Therapeutics granted clinical trial authorization for lead multiple sclerosis therapeutic candidate PTD802

Pheno Therapeutics granted clinical trial authorization for lead multiple sclerosis therapeutic candidate PTD802

Study highlights the critical role of TLR7 in sex-biased Alzheimer’s-related demyelination

Study highlights the critical role of TLR7 in sex-biased Alzheimer’s-related demyelination

Spatial transcriptomics uncovers tissue niches in multiple sclerosis

Spatial transcriptomics uncovers tissue niches in multiple sclerosis

Elevated antibody responses to Epstein-Barr virus linked to increased risk of multiple sclerosis

Elevated antibody responses to Epstein-Barr virus linked to increased risk of multiple sclerosis

Research identifies crucial links between dietary choices and progression of multiple sclerosis

Research identifies crucial links between dietary choices and progression of multiple sclerosis

Study explores microglial response to chronic hyponatremia and rapid sodium correction

Study explores microglial response to chronic hyponatremia and rapid sodium correction

Disrupted glucose transport in oligodendrocytes linked to myelin thinning and aging in new research

Disrupted glucose transport in oligodendrocytes linked to myelin thinning and aging in new research

Study explores the effects of hyperosmotic stress on microglial cells

Study explores the effects of hyperosmotic stress on microglial cells

MS Australia unveils new grants to revolutionize multiple sclerosis diagnosis and care

MS Australia unveils new grants to revolutionize multiple sclerosis diagnosis and care

Researchers identify a potential therapeutic target for advanced multiple sclerosis

Researchers identify a potential therapeutic target for advanced multiple sclerosis

AI and imaging advances revolutionize multiple sclerosis diagnosis

AI and imaging advances revolutionize multiple sclerosis diagnosis

Dartmouth research unlocks extended cell death pathway in aging brain cells

Dartmouth research unlocks extended cell death pathway in aging brain cells

Study highlights potential therapeutic target for immune-related disorders

Study highlights potential therapeutic target for immune-related disorders

Noninvasive gamma therapy may hold promise for treating chemo brain

Noninvasive gamma therapy may hold promise for treating chemo brain

Cytokine interferon-gamma can be a disease-modifying therapeutic target in multiple system atrophy

Cytokine interferon-gamma can be a disease-modifying therapeutic target in multiple system atrophy

Widespread pain makes exercise a challenge for some patients with multiple sclerosis

Widespread pain makes exercise a challenge for some patients with multiple sclerosis

Abnormal myelin, not loss of myelin, may drive axon degeneration in myelin diseases

Abnormal myelin, not loss of myelin, may drive axon degeneration in myelin diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.